logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11 Age at first use and primary drug. EU, Croatia, Norway and Turkey, 2011 or most recent year available

Part (v) Age at first use distribution, New inpatient clients (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates7.340.627.913.46.12.80.90.922.02742220
Cocaine12.945.120.910.54.93.80.81.121.1526107
Stimulants11.158.919.26.52.21.20.40.519.5110191
Hypnotics and sedatives6.123.317.614.113.05.36.514.129.6262168
Hallucinogens3.465.517.213.80.00.00.00.019.62914
Volatile substances44.248.73.51.80.00.90.90.016.51138
Cannabis 38.647.38.72.91.10.70.60.117.11405281
Other substances 7.830.627.214.711.94.41.32.223.9320202
Total15.844.620.89.64.72.31.01.320.764981091
 

Notes:

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012 — Table TDI — outpatient treatment centres.

Page last updated: Friday, 26 April 2013